PRESS RELEASE published on 10/01/2024 at 02:00, 1 year 7 months ago Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines Moderna Inc. and Cenra Healthcare enter joint agreement to co-promote mRNA respiratory vaccine portfolio in Taiwan, enhancing public health initiatives. Details undisclosed Moderna Taïwan MRNA Vaccine Cenra Healthcare Joint Agreement
PRESS RELEASE published on 10/01/2024 at 00:51, 1 year 7 months ago Inside Information: News release on accounts, results Valerio Therapeutics annonce ses résultats financiers du Premier Semestre 2024 et fait le point sur ses activités, y compris l'acquisition d'Emglev Therapeutics et le développement de la plateforme PlatONTM Résultats Financiers Biotechnologie Valerio Therapeutics Emglev Therapeutics Plateforme PlatONTM
PRESS RELEASE published on 10/01/2024 at 00:40, 1 year 7 months ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 23:00, 1 year 7 months ago Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
PRESS RELEASE published on 09/30/2024 at 23:00, 1 year 7 months ago Biophytis publie ses comptes semestriels et fait le point sur ses activités Biophytis publie ses comptes semestriels et fait le point sur ses activités. La société présente ses résultats financiers pour le premier semestre 2024 et annonce les prochaines étapes de développement de ses programmes cliniques Biophytis Partenariat BIO101 Obésité Comptes Semestriels
REGULATED PRESS RELEASE published on 09/30/2024 at 23:00, 1 year 7 months ago Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America Financial Results Biophytis Latin America BIO101 OBA Program
REGULATED PRESS RELEASE published on 09/30/2024 at 23:00, 1 year 7 months ago Biophytis publie ses comptes semestriels et fait le point sur ses activités Biophytis publie ses résultats semestriels 2024, annonce son programme OBA dans l'obésité et un accord avec Blanver pour l'Amérique Latine Résultats Semestriels Biophytis Biotechnologie Programme OBA Accord Blanver
PRESS RELEASE published on 09/30/2024 at 23:00, 1 year 7 months ago Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 2024 Clean Air Metals Inc. announces unaudited financial results for the six-month period ended July 31, 2024. Total assets $37.6M, cash $4.2M, working capital $923K, equity $33.7M. CEO confident in project development. Exploration company Thunder Bay North project advancing with notable resource potential Financial Results Clean Air Metals Inc. Exploration Project Development Thunder Bay North Project
PRESS RELEASE published on 09/30/2024 at 22:40, 1 year 7 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
PRESS RELEASE published on 09/30/2024 at 22:40, 1 year 7 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Published on 05/16/2026 at 01:15, 52 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 2 hours 7 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 hours 57 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 3 hours 7 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 5 hours 57 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 7 hours 56 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 8 hours 33 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 10 hours 59 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 11 hours 7 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 15 hours 57 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 17 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 8 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES